These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24956661)

  • 1. [Hyperhidrosis - an underestimated comorbidity. Great discomfort should not be tolerated].
    MMW Fortschr Med; 2014 Apr; 156(7):58-9. PubMed ID: 24956661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperhidrosis. Effective reduced sweating with methantheline bromide].
    MMW Fortschr Med; 2012 May; 154(10):68-9. PubMed ID: 22803247
    [No Abstract]   [Full Text] [Related]  

  • 3. [In process].
    Jäger-Becker D
    Med Monatsschr Pharm; 2016 Aug; 39(8):349-50. PubMed ID: 29984953
    [No Abstract]   [Full Text] [Related]  

  • 4. Willingness-to-pay and patient-defined benefits in the treatment of hyperhidrosis: results from the first German health services research study in hyperhidrosis.
    Müller C; Augustin M
    Br J Dermatol; 2013 Feb; 168(2):448-50. PubMed ID: 22803816
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique pattern of hyperhidrosis.
    Lewis VJ; Holt PJ
    Arch Dermatol; 2006 Feb; 142(2):264. PubMed ID: 16490867
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniofacial hyperhidrosis in post-menopausal women.
    Alsharqi A; Wilson NJ
    Australas J Dermatol; 2012 May; 53(2):158-9. PubMed ID: 22571572
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of oxybutynin for treating plantar hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Yazbek G; Neves S; Puech-Leao P
    Int J Dermatol; 2013 May; 52(5):620-3. PubMed ID: 23590378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral mydriasis due to a topical "anti-sweat" preparation.
    Johnson C; Smereck J
    J Emerg Med; 2013 Mar; 44(3):673-4. PubMed ID: 23158696
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxybutynin therapy for generalized hyperhidrosis.
    Tupker RA; Harmsze AM; Deneer VH
    Arch Dermatol; 2006 Aug; 142(8):1065-6. PubMed ID: 16924061
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxybutynin as an alternative treatment for hyperhidrosis.
    Delort S; Marchi E; Corrêa MA
    An Bras Dermatol; 2017; 92(2):217-220. PubMed ID: 28538882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkable improvement of relapsing dyshidrotic eczema after treatment of coexistant hyperhidrosis with oxybutynin.
    Markantoni V; Kouris A; Armyra K; Vavouli C; Kontochristopoulos G
    Dermatol Ther; 2014; 27(6):365-8. PubMed ID: 25039723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managing hyperhidrosis].
    MMW Fortschr Med; 2012 Jun; 154(12):36. PubMed ID: 22880296
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical glycopyrrolate for axillary hyperhidrosis.
    Mackenzie A; Burns C; Kavanagh G
    Br J Dermatol; 2013 Aug; 169(2):483-4. PubMed ID: 23496205
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of thioridazine in palliative care patients with troublesome sweating.
    Abbas SQ
    J Pain Symptom Manage; 2004 Mar; 27(3):194-5. PubMed ID: 15010097
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
    Madan V; Beck MH
    Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.